Valuation: Boston Scientific Corporation

Capitalization 78.3B 67.28B 61.55B 58.46B 108B 7,543B 109B 737B 286B 3,569B 294B 288B 12,440B P/E ratio 2026 *
19.4x
P/E ratio 2027 * 18.4x
Enterprise value 84.6B 72.68B 66.5B 63.16B 116B 8,149B 118B 796B 308B 3,856B 317B 311B 13,440B EV / Sales 2026 *
3.9x
EV / Sales 2027 * 3.44x
Free-Float
84.7%
Yield 2026 *
-
Yield 2027 * -
1 day+6.81%
1 week+4.57%
Current month-3.12%
1 month-8.49%
3 months-26.84%
6 months-43.75%
Current year-41.47%
1 week 52.52
Extreme 52.52
55.86
1 month 52.52
Extreme 52.52
66.88
Current year 52.52
Extreme 52.52
100.9
1 year 52.52
Extreme 52.52
109.5
3 years 48.35
Extreme 48.35
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 31/10/2011
Director of Finance/CFO 52 29/06/2025
Chief Operating Officer 58 30/04/2022
Director TitleAgeSince
Chairman 61 02/05/2016
Director/Board Member 74 28/02/2014
Director/Board Member 74 14/04/2016
Change 5d. change 1-year change 3-years change Capi.($)
+6.85%+4.57%-47.67%+4.43% 78.3B
+0.82%-2.66%+6.44%-15.85% 163B
+4.52%+4.52%-21.82%+40.62% 149B
+1.25%-1.60%-16.58%-27.64% 115B
+1.27%+6.54%+5.36%-5.94% 46.86B
+0.78%+0.27%-31.61%-36.54% 43.31B
+1.13%-4.50%-7.29%+24.01% 32.32B
+0.56%+0.57%-1.18%-13.19% 31.57B
+1.77%+3.07%-19.14%-8.63% 29.28B
-2.52%-8.37%-30.93%-49.50% 28.5B
Average +1.67%-3.79%-16.44%-8.82% 71.68B
Weighted average by Cap. +2.27%-4.50%-14.89%-3.50%

Financials

2026 *2027 *
Net sales 21.68B 18.63B 17.04B 16.19B 29.8B 2,089B 30.31B 204B 79.06B 988B 81.36B 79.64B 3,444B 23.62B 20.29B 18.57B 17.63B 32.47B 2,275B 33.02B 222B 86.13B 1,077B 88.64B 86.76B 3,752B
Net income 3.96B 3.4B 3.11B 2.96B 5.44B 381B 5.53B 37.24B 14.43B 180B 14.85B 14.54B 629B 4.18B 3.59B 3.28B 3.12B 5.74B 402B 5.84B 39.31B 15.23B 190B 15.68B 15.35B 664B
Net Debt 6.29B 5.41B 4.95B 4.7B 8.65B 606B 8.8B 59.22B 22.95B 287B 23.62B 23.12B 1T 2.9B 2.49B 2.28B 2.16B 3.99B 279B 4.05B 27.28B 10.57B 132B 10.88B 10.65B 461B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
18/05/26 55.86 $ +6.04% 9,270,844
15/05/26 52.68 $ -1.62% 14,843,339
14/05/26 53.55 $ +0.92% 14,595,126
13/05/26 53.06 $ -1.92% 17,994,229
12/05/26 54.10 $ +1.37% 15,917,843
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
52.68USD
Average target price
85.19USD
Spread / Average Target
+61.71%

Quarterly revenue - Rate of surprise